"Given the rapidly evolving GLP-1 landscape, it may be prudent for plan sponsors to: [1] Evaluate the use of prior authorization, step therapy, quantity limits, or outcome-based wellness designs to manage utilization and cost exposure.... [2] Analyze HIPAA nondiscrimination risks by limiting mid-year changes to coverage and confirming that similarly situated plan participants, regardless of disability status, are subject to the same GLP-1 coverage terms. [3] Ensure all utilization management techniques are analyzed in the plan's comparative analysis ... to ensure parity in the plan as written and in operation."  MORE >>